Navigation Links
Congenital rubella syndrome nearly eradicated in the US

Congenital rubella syndrome, a birth defect caused by the rubella virus (also known as German measles), has practically been eliminated in the U.S., according to a statement published in the April 2006 issue of Birth Defects Research Part A, the official journal of The Teratology Society. The journal is available online via Wiley InterScience at

Endorsed by the Teratology Society, the Organization of Teratology Information Specialists (OTIS), the Neurobehavioral Teratology Society, and the Behavioral Toxicology Society, the statement notes that rubella is no longer an endemic disease in this country and congenital rubella syndrome "is almost a thing of the past in the United States." Birth defects resulting from rubella may include blindness, deafness, and congenital heart disease. A rubella epidemic in the early 1960s caused more than 11,000 fetal deaths and 20,000 infants to be born with congenital rubella syndrome, but a more effective vaccine introduced in the 1970s has helped in eliminating transmission of rubella from expectant mothers to their unborn babies.

"Effectively, congenital rubella syndrome has been nearly eradicated from the United States," according to the statement. There were fewer than 10 cases or rubella reported in the U.S. last year and in the past 5 years there have only been 4 cases of congenital rubella syndrome reported, only one of which was in a child whose mother had been born in the U.S.

The remarkable success of the immunization program to eliminate rubella is due to joint efforts by the Centers for Disease Control and Prevention, various state and local health departments, the American Academy of Pediatrics, the American College of Obstetrics and Gynecology, and the March of Dimes, according to the statement. Maintaining high rubella immunization rates is crucial to the continue d success of these efforts. The statement concludes: "Effective strategies, such as continued universal childhood and adolescent immunization, must be secured to extend this success worldwide."


Source:John Wiley & Sons, Inc.

Related biology news :

1. 15-year hunt finds cause of pseudothalidomide syndrome
2. Gene for immune deficiency syndromes found
3. Removing DNA repair gene causes metabolic syndrome
4. Researchers link two more genes to sudden infant death syndrome
5. Down syndrome: Its not just the age factor
6. A potential biological cause for sudden infant death syndrome
7. Drug treatment improves learning in mice with Down syndrome symptoms, Stanford/Packard study shows
8. Angelman syndrome deficits rescued in mice
9. Chronic fatigue syndrome impairs a persons slow wave activity during sleep
10. New research says winning a Nobel Prize adds nearly 2 years to your lifespan
11. Breast tumors in mice eradicated using cancer vaccine
Post Your Comments:

(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... , England , November 26, 2015 ... Lightpoint Medical, an innovative medical device company specializing in imaging ... grant from the European Commission as part of the Horizon ... the company to carry out a large-scale clinical trial in ... -->      (Logo: , --> ...
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, Inc. ... participate in a fireside chat discussion at the Piper ... York . The discussion is scheduled for Wednesday, ... .  A replay will be available for ... Stilwell  , Julie NormartVP, Corporate Communications and Business ...
Breaking Biology Technology: